Press Releases

4/4/2014    Nominations Being Accepted for PDA Board of Directors
Bethesda, Md., April 4, 2014 – The Parenteral Drug Association (PDA) announced the opening of the nomination process for Board members for the 2015-2017 term.
2/20/2014    PDA Announces Opening Plenary Speakers for the 2014 Annual Meeting
Bethesda, Md., February 18, 2014 – The Parenteral Drug Association (PDA) is proud to announce that Dr. Mark B. McClellan, Director, Health Care Innovation and Value Initiative for the Brookings Institute and former FDA Commissioner and Dr. Rahul Singhvi, Chief Operating Officer, Vaccines, Takeda Pharmaceuticals International will be the Opening Plenary Speakers at the 2014 PDA Annual Meeting, April 7-9, JW Marriott San Antonio Hilly Country Resort & Spa in San Antonio, Texas.
12/18/2013    PDA Announces Elections Results
Bethesda, Md. - The Parenteral Drug Association announced the results of its 2014 Board of Directors and Officers Elections.
12/2/2013    PDA Courses Address Need for Knowledge of Aseptic Processing
Bethesda, Md. - Producing sterile products using aseptic processing technology is challenging and the FDA is aware of these challenges.
10/29/2013    Singapore Becomes Newest Chapter in Parenteral Drug Association
Bethesda, Md. – 45 pharmaceutical professionals have formed the Singapore chapter of PDA, bringing to 24 the number of chapters across the globe. 
10/28/2013    PDA/FDA JOINT REGULATORY CONFERENCE: Great Place to Learn From Regulators
Bethesda, Md. – Many of the nearly 1,000 people who attended the 23rd Annual PDA/FDA Joint Regulatory Conference said the event provided them the opportunity to hear directly from regulators on the issues that affect them most, and from industry experts on how they are responding to these same issues.
10/9/2013    PDA Announces Changes In Membership Rates For Government Employees
Bethedsa, MD. - For government regulators across the globe, the Parenteral Drug Association is offering free or greatly reduced electronic membership fees.
9/20/2013    Course Answers Questions About Single Use Systems
BETHESDA, M.D. – When the topic of single use systems comes up among pharmaceutical manufacturers, there seems to be more questions than answers.
9/11/2013    Parenteral Drug Association Elections Begin
Bethesda, Md. – For members of the Parenteral Drug Association, this is election season – for open seats on the 2014 Board of Directors.
8/19/2013    INTERPHEX and PDA Announce Agreement
NORWALK, CT, Aug. 19, 2013 – International Pharmaceutical Expo (INTERPHEX), the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry and the Parenteral Drug Association (PDA) are pleased to announce a three-year Sponsorship Agreement.
2/22/2013    FDA’s Rick Friedman and Rebecca Rodriguez Confirmed as Closing Plenary Speakers for PDA Human Factor
PDA announced today that Richard Friedman, Associate Director OMPQ, U.S. FDA, and Rebecca Rodriguez, Consumer Safety Officer, U.S. FDA, have been confirmed to deliver the closing plenary talks at the 2013 Human Factors and Human Error Reduction Workshop.
2/1/2013    PDA Announces Establishment of New Chapter in Texas
“PDA has a long history of members in Texas and we are excited to introduce the PDA Texas Chapter. The area has a great mix of established pharma/bio industry, and is becoming a hub of new development, especially in new therapies.
1/7/2013    PDA Establishes the Martin VanTrieste Pharmaceutical Science Award
Bethesda, Md., January 7, 2013 – The Parenteral Drug Association (PDA) is proud to announce the establishment of the Martin VanTrieste Pharmaceutical Science Award.
12/14/2012    PDA Announces the Results of the 2013 Election
PDA is pleased to announce the results of the 2013 Board of Directors election. The elected candidates will fill their term beginning on January 1, 2013. Thank you to all who voted!
12/10/2012    PDA’s New Technical Report Portal is Now Open!
PDA Technical Reports are highly valued, global technical documents prepared by member-driven Task Forces comprised of content experts, including scientists and engineers working in the pharmaceutical and biopharmaceutical industry, regulatory authorities and academia.
10/31/2012    PDA Announces Establishment of New Chapter in India
Bethesda, Md., October 31, 2012 – The Parenteral Drug Association (PDA) is proud to announce the founding of the PDA India Chapter, which will serve PDA members in India.
9/21/2012    PDA’s Announces New Technical Report (TR) Portal by the End of 2012
“This is the most innovative and significant member benefit ever offered by The Parenteral Drug Association (PDA),” said Richard M. Johnson, PDA President. “We have been working hard on enhancing our member value and we believe that releasing this new Technical Report Portal by the end of 2012 is a breakthrough benefit that you just don’t see anywhere.
9/7/2012    PDA’s 2012 Universe of Pre-filled Syringes & Injection Devices - the Best Mindshare in the Industry
Our industry is entering a challenging phase for the next decade in the area of pre-filled syringes & injection devices. Costs and regulatory demands exert downward pressure on our ability to introduce devices that are safe and effective. Patients and their needs continue to grow while ever more complex molecules continue to challenge our material selection. Regulatory requirements, industry experience and evolving market trends are critical considerations to ensure a complete understanding of the application of pre-filled syringes and injection devices to drug delivery.
7/16/2012    PDA Pres. Signs Landmark Agreement with The St. Petersburg’s State Chemical Pharm. Academy (SPCPA)
Bethesda, Md., July 16, 2012 – St Petersburg, Russia (June 22, 2012) – The Parenteral Drug Association (PDA) and The Saint-Petersburg State Chemical-Pharmaceutical Academy (SPCPA) have signed a Memorandum of Understanding to develop a GMP and Regulatory Affairs Training Center in the area of pharmaceutical manufacturing in St. Petersburg (the Training Center).
4/23/2012    PDA Announces a Landmark Workshop on QbD
The Parenteral Drug Association (PDA) is coordinating a critical discussion on the implementation of QbD concepts in vaccine development.